| P2093 | author name string | Clarissa Sema | |
| | Erin J McDade | |
| | Frederick Kittell | |
| | Jeffery T Zobell | |
| | Kevin Epps | |
| | Mariela A Duval | |
| | Rebecca S Pettit | |
| | Stacy J Peters | |
| P2860 | cites work | Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. | Q34098657 |
| | Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis | Q35259780 |
| | Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 |
| | National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations | Q36063806 |
| | Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. | Q36924692 |
| | Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations | Q37591703 |
| | Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides. | Q38133781 |
| | European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre | Q38214214 |
| | Management of pulmonary disease in patients with cystic fibrosis | Q41002731 |
| | Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients | Q43276198 |
| | A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients | Q43425473 |
| | Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study | Q43599722 |
| | Once-daily tobramycin in the treatment of adult patients with cystic fibrosis | Q43897091 |
| | Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis | Q44161000 |
| | Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial | Q45262881 |
| | A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis | Q46069692 |
| | Pharmacodynamics of tobramycin in patients with cystic fibrosis | Q46554477 |
| | Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? | Q80050474 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 239-246 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG | Q26842666 |
| P1476 | title | Tobramycin and Beta-Lactam Antibiotic Use in Cystic Fibrosis Exacerbations: A Pharmacist Approach | |
| P478 | volume | 21 | |